Verisk Analytics, Inc. Profile Avatar - Palmy Investing

Verisk Analytics, Inc.

Verisk Analytics, Inc. provides data analytics solutions in the United States and internationally. The company provides predictive analytics and decision support solutions to customers in rating, underwriting, claims, catastrophe and weather risk, global…
Consulting Services
US, Jersey City [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -15.11 94.16 110.92
Graham Fair Price 8.24 8.24 7.61
PEG -80.61 1.38 -7.12
Price/Book 6.08 118.20 111.43
Price/Cash Flow -40.26 105.23 176.15
Prices/Earnings -23.57 37.97 49.69
Price/Sales -7.11 47.38 51.01
Price/FCF -40.26 105.23 176.15
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -14.62 0.57 0.67
Operating Margin 18.08 0.44 0.37
ROA 22.63 0.05 0.04
ROE 0.56 0.78 38.80
ROIC 0.06 0.08 40.50
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 < 0.005 4999.84
Dividends QOQ < 0.005 0.15 4362.21
EBIT QOQ -0.11 0.23 109.03
EPS QOQ -0.07 0.28 294.17
FCF QOQ < 0.005 0.62 40138.35
Revenue QOQ < 0.005 0.04 6603.96
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 33.62 < 0.005 -100.00
Days Sales Outstanding (DSO) 47.54 66.32 39.52
Inventory Turnover 2.68 303700000.00 11345114842.53
Debt/Capitalization 0.91 0.91 0.18
Quick Ratio 0.86 0.94 9.86
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 2.14 1.97 -8.13
Cash 2.10 2.49 18.65
Capex -0.39 -0.39 1.05
Free Cash Flow 1.36 2.21 63.14
Revenue 4.68 4.91 4.92
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.05 1.09 4.15
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 8.30 7.16 -13.73
Naive Interpretation Member
06 - Financial Health · Bad
End of VRSK's Analysis
CIK: 1442145 CUSIP: 92345Y106 ISIN: US92345Y1064 LEI: - UEI: -
Secondary Listings